undamentalytics Newsletter
Sign in

Mobile-health Network Solutions (MNDR) stock

Add to watchlist

Add holding +

NASDAQ: MNDR Nasdaq Health Care Technology

C Fundamentals grade

Mobile-health Network Solutions is a US-listed company in the health care technology industry. Its financial year ends in June.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$2.7

Revenue-to-maturity cash-flow model

Base case. Range ~$2.4–$4.3 across our lower- and higher-growth cases (0%–6.2% a year).

Price vs value

No Buy/Hold/Sell rating is issued: only 1 valuation models apply; a rating needs 3.

Mobile-health Network Solutions valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Funds4 adding, 0 cuttingOf 1 active managers that changed their stake, 1 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Mobile-health Network Solutions files

Where Mobile-health Network Solutions stands after its latest Filing

Revenue for the twelve months was $8m, up 1.2% on a year earlier, against a decline of 45.3% a quarter earlier. Free-cash-flow margin fell to -19.7% from 13.7% a year earlier. The diluted share count is up 265.5% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades C. It passes 2 of our 2 financial-health checks. Our revenue-to-maturity cash-flow model value is $2.73 a share, against a share price of $0.98.

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Mobile-health Network Solutions's trailing-twelve-month revenue grew 1.2% year on year, with a free-cash-flow margin of -19.7%. Where it stands out: days sales outstanding of 4 days ranks 1 of 21 health care technology companies we cover. Where it lags: change in share count of 265.5% ranks 19 of 19 health care technology companies we cover.

Current signal Balance sheet growing far ahead of sales: Total assets grew 156% year over year while revenue grew 1% — the balance sheet is expanding 154 points faster than the business it supports.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Growth speeding up. The growth rate is 46.5 points higher than a quarter earlier.
  • Net cash. Cash exceeds long-term debt by $0.0bn.

Things to watch

  • Burning cash. Free cash flow was -19.7% of revenue over the last 12 months.
  • Heavy stock-based pay. Stock pay equals 19.9% of revenue, against a median of 9.7% for health care technology companies we cover: a real cost that cash-flow figures leave out.
  • Share dilution. Diluted shares rose 265.5% in a year.
  • Volatile shares. Over the past year the shares showed annualised volatility of 319% and a beta of -0.1 against the S&P 500.
  • Below peers: gross margin. Gross margin of 21.2% ranks 13 of 14 health care technology companies we cover (median 58.2%).

Price chart

  • 1 day-1.9%
  • 1 week+3.6%
  • 1 month-27.4%
  • This year-82.1%
  • 1 year-93.9%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$7.7M
Net margin
-41.2%
EPS (TTM, diluted)
$-5.03

Growth

Revenue growth
+1.2%
Change in growth rate
+46.5 pts
Share count change
+265.5%

Cash

Free cash flow (TTM)
-$1.5M
FCF margin
-19.7%
Stock pay % of revenue
19.9%

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

No recent updates are available for MNDR from the sources we follow. See filings →

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Mobile-health Network Solutions valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: only 1 valuation models apply; a rating needs 3.

Valuation models

We value Mobile-health Network Solutions as an operating company, with every model that fits that kind of business. Cost of equity 9.7%: the 10-year Treasury yield (4.9%) plus a beta of 1.06 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. ~$2.7 ~$2.4–$4.3 Primary model, counts double
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. — Does not apply: no positive earnings in the latest twelve months
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. — Does not apply: the model gives no positive value
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. — Does not apply: return on equity is not positive
Price-to-sales vs peers Sales per share times peers' typical price-to-sales; used only when earnings are negative. ~$6.3 ~$7.8–$52 Left out: out of range vs price (6.60x)
Combined value Weighted average of the models that apply: the primary model (revenue-to-maturity model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$2.7 ~$2.4–$4.3 1 model

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Mobile-health Network Solutions with Health Care Technology in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 202420252026
Share price$338.40$32.10$3.06
Market value$49m$6m$2m
+ Net debt (− = net cash)−$7m−$1m−$3m
Enterprise value$42m$5m−$609663
Multiples
Price / sales 3.5x0.7x0.3x
Price / earnings ———
Price / free cash flow ———
EV / EBITDA ———

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

No analyst estimates are published for Mobile-health Network Solutions: too few analysts cover it.

Positioning

Short interest
3.1%
of tradable shares
Days to cover
0
at average volume
Short interest, 1 month
+243%
to October 15, 2026
Held by institutions
1%
of shares
Held by insiders
10.3%
of shares
Employees
73
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Return and risk by year

Calendar year 20252026 to date
Return
MNDR−93%−82%
Industry peers (median)−27%−26%
S&P 500+18%+11%
Months that ended higher
MNDR17%9%
S&P 50075%46%
Largest fall from a high during the year
MNDR−98%−92%
S&P 500−19%−9%

Worst fall since April 10, 2024: 100% from April 19, 2024 to October 9, 2026. Getting back needed a 769876% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$0.85 – $28.50
From 52-week high
−96.6%
vs 50-day average
−26.6%
vs 200-day average
−74.8%
Volatility (1 year)
319%
Beta vs S&P 500
-0.15

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Mobile-health Network Solutions in five measures

Fundamentals grade C
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Mobile-health Network Solutions
$6M $8M $10M $12M $14M FY22 Q4 FY23 Q4 FY24 Q4 FY25 Q4 FY26 Q4 Revenue (TTM), FY22 Q4: $7M Revenue (TTM), FY23 Q4: $7.9M Revenue (TTM), FY24 Q4: $14M Revenue (TTM), FY25 Q4: $7.6M Revenue (TTM), FY26 Q4: $7.7M $7.7M

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period Revenue (TTM)
FY22 Q4 $7M
FY23 Q4 $7.9M
FY24 Q4 $14M
FY25 Q4 $7.6M
FY26 Q4 $7.7M
Revenue growth, TTM YoY Mobile-health Network Solutions
-50% 0% 50% 100% FY23 Q4 FY24 Q4 FY25 Q4 FY26 Q4 Revenue growth, TTM YoY, FY23 Q4: 12.7% Revenue growth, TTM YoY, FY24 Q4: 77.4% Revenue growth, TTM YoY, FY25 Q4: -45.3% Revenue growth, TTM YoY, FY26 Q4: 1.2% 1.2%

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 12.7%
FY24 Q4 77.4%
FY25 Q4 -45.3%
FY26 Q4 1.2%
FCF margin (TTM) Mobile-health Network Solutions
-60% -40% -20% 0% 20% FY22 Q4 FY23 Q4 FY24 Q4 FY25 Q4 FY26 Q4 FCF margin (TTM), FY22 Q4: 13.7% FCF margin (TTM), FY23 Q4: -30.9% FCF margin (TTM), FY24 Q4: -46.8% FCF margin (TTM), FY25 Q4: -57.8% FCF margin (TTM), FY26 Q4: -19.7% -19.7%

Source: SEC EDGAR filings. Retrieved Invalid Date.

View chart data
Period FCF margin (TTM)
FY22 Q4 13.7%
FY23 Q4 -30.9%
FY24 Q4 -46.8%
FY25 Q4 -57.8%
FY26 Q4 -19.7%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 20-F, 20-F/A. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2022 Jun 2022 2023 Jun 2023 2024 Jun 2024 2025 Jun 2025 2026 Jun 2026
Income
Revenue 7 8 14 8 8
Gross profit 2 1 3 1 2
Net income 0 −3 −16 −3 −3
Diluted EPS $0.06 −$30.24 −$108.57 −$19.50 −$5.03
Growth (year on year)
Revenue — +12.7% +77.4% −45.3% +1.2%
Margins
Gross margin 27.7% 13.9% 18.2% 16.7% 21.2%
Net margin 1.3% −40.8% −111.7% −44.3% −41.2%
Free-cash-flow margin 13.7% −30.9% −46.8% −57.8% −19.7%
Cash flow
Cash from operations 1 −2 −6 −4 −2
Capital spending 0 0 0 0 0
Free cash flow 1 −2 −7 −4 −2
Stock-based pay — — 9 0 2
Free cash flow after stock pay — — −16 −5 −3
Balance sheet
Cash — 2 7 1 3
Total debt 0 0 0 0 0
Net debt (negative = net cash) — −2 −7 −1 −3
Diluted shares 4m — — — —
Returned to shareholders
Buybacks — 7 — — —
Total returned — 7 — — —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 2 checks passed · June 30, 2026
What it owns · $11m
Short-term assets $6mLonger-term assets $6m
What it owes, and who funded it · $11m
Short-term liabilities $1mLonger-term liabilities $0mShareholders' equity $10m
  • Short-term assets cover short-term liabilities $6m of assets due within a year against $1m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $6m short-term assets against $63,206 of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Mobile-health Network Solutions's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Diluted share count
+265.5%
year over year
Sales & admin spending
26.1%
of revenue
Days sales outstanding
4 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in health care technology
Last 12 months unless stated MNDR WORX DRIO HCTI AIFF ONMD Median
Revenue, last 12 months $8m $3m $21m $26m $2m $1m $292m
Revenue growth, last 12 months 1.2% 3.1% −22.6% 116.4% 320.3% 216.5% 8.8%
Revenue growth, 3-year average — −9.9% −7.6% −14.9% −41.3% — 0.8%
Revenue growth, latest quarter — 3.4% −3.6% 158.4% 71.9% 88.4% 7.4%
Gross margin 21.2% 44.7% 58.2% 21.5% 44.6% −68.8% 58.6%
Operating margin — −20.1% −151.6% −57.4% −508.1% −695.7% −12.5%
Operating margin, 3-year average — −36.9% −213.6% −40.6% <−999% <−999% −18.8%
Net margin −41.2% −80.5% −169.9% −66.3% −506.2% −584.2% −12.5%
Cash from operations / revenue −19.7% −25.5% −120.7% −62.4% −388.6% −472.3% 9.7%
Free-cash-flow margin −19.7% −86.6% −121.3% −62.4% −388.6% −473.4% 9.2%
Free-cash-flow margin, 3-year average — — −144.7% −44.7% <−999% −910.1% 8.2%
Stock pay / revenue 19.9% 9.5% 33.6% 3.2% 62.0% 173.1% 9.5%
Change in share count 265.5% 207.2% 25.9% — 27.7% 62.6% 2.9%

Median of all 23 companies we cover in health care technology. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

23 health care technology companies
Measure Company Peer median Rank
Revenue growth Growth 1.2% 8.8% 15 of 23
Change in growth rate Growth +46.5pp -0.3pp 2 of 23
Gross margin Profitability 21.2% 58.2% 13 of 14
Net margin Profitability -41.2% -12.5% 15 of 23
Free-cash-flow margin Cash generation -19.7% 10.6% 17 of 22
Stock pay as % of revenue Cash generation 19.9% 9.7% 17 of 22
Change in share count Balance sheet 265.5% 2.6% 19 of 19
Days sales outstanding Balance sheet 4 days 58 days 1 of 21

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Who owns it

Funds buying and selling
Reported value
$107,711
Institutions reporting
4
Positions opened / closed
4 / 0

Top buyers and sellers, Q2 2026: 4 institutions bought and 0 sold ; the biggest buyer was HRT Financial LP (+17K shares) . See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
HRT Financial LP $51,000 17K 47.3% —
Citadel Advisors LLC $32,476 11K 30.2% —
UBS Group AG $24,189 8K 22.5% —
Sbi Securities Co., Ltd. $46 0K 0.0% —

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Mobile-health Network Solutions's complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $0 net buying

No open-market insider trades reported in the last 12 months.

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Recent SEC filings

Data status

When each part of this page on Mobile-health Network Solutions was last updated.

DataLast updatedSource
Share priceExchange closing prices
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Mobile-health Network Solutions in brief

What does Mobile-health Network Solutions do?
Mobile-health Network Solutions is a US-listed company in the health care technology industry. Its financial year ends in June.
What is Mobile-health Network Solutions's stock ticker?
Mobile-health Network Solutions trades under the ticker MNDR on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Mobile-health Network Solutions's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Mobile-health Network Solutions reported revenue of $7.7M, 1.2% higher than a year earlier, according to its SEC filings.
What is Mobile-health Network Solutions's free cash flow?
Mobile-health Network Solutions's free-cash-flow margin is -19.7% of revenue over the trailing twelve months, ranking 17 of the 22 health care technology companies we cover.
Who are Mobile-health Network Solutions's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are HRT Financial LP, Citadel Advisors LLC and UBS Group AG. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Mobile-health Network Solutions's market cap?
On June 30, 2026, Mobile-health Network Solutions's market capitalisation was about $1.9M and net debt of -$2.5M. Market figures come from third-party market data and may be delayed.
Who are Mobile-health Network Solutions's competitors?
In our Health Care Technology peer group, the companies closest to Mobile-health Network Solutions are Scworx Corp., Dariohealth Corp., Healthcare Triangle, Inc., Firefly Neuroscience, Inc. and Onemednet Corp. The side-by-side comparison below sets their revenue, margins and growth against Mobile-health Network Solutions's.